Polymorphisms in tyrosine protein-kinase 2 (TYK2) are associated with a reduced risk of several autoimmune diseases, including T1D, ulcerative colitis, and rheumatoid arthritis. The gene discussed is PTK2; the disease is type 1 diabetes mellitus.